SELECT THE RIGHT TEST FOR YOU
With VERACITY and VERAgene, you have the option of taking a highly accurate (>99%) and safe non-invasive prenatal test (NIPT) to check for genetic conditions of the fetus before birth with no risk for miscarriage. In both NIPTs, cell-free DNA from the mother’s blood is analyzed to detect potential changes in the genome including aneuploidies and microdeletions. Additionally, VERAgene tests for single gene (monogenic) disorders in the biological parents. Both tests are recommended for any pregnant women, independent of age and risk category and can be done from 10th week of pregnancy. Choose VERACITY to detect the most common fetal aneuploidies and microdeletions which occur more frequent with advanced maternal age. Choose VERAgene if you additionally want to simultaneously screen for other microdeletions and monogenic diseases that do not have any maternal age-associated risk and can have a significant impact on life quality. The outcome of the test can help parents take informed decisions about possible treatments and clinical management.
VERACITY
Detection of the most common fetal aneuploidies and microdeletions (all included in VERAgene as well) which occur more frequent with advanced maternal age. VERACITY has been validated by several clinical studies for single and twin pregnancies, and can also be used in pregnancies conceived through in-vitro fertilization (IVF).
VERAgene
Simultaneous screen for aneuploidies (included in VERACITY), microdeletions and monogenic diseases provides a comprehensive solution to prospective parents using a single test. Genetic diseases screened in VERAgene are associated with significant impact on life quality.
LATEST ARTICLES
We’re thrilled to share the results of Medicover Genetics essay competition for high school students as well as the two winning essays. This competit…
Cystic fibrosis (CF) is a life-threatening, progressive, inherited condition that causes severe damage to the body, primarily affecting the organs of…
Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. It affects physical growth, facial features, and cogni…
Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D…
Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f…
Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced …
Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso…
Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co…
The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study…
Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a…
